This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Ppl (Holdings) Limited, University of Copenhagen. Active years: 2003-2010.
Company Filing History:
Years Active: 2003-2010
Title: An Insight into the Innovations of Alan Archibald
Introduction
Alan Archibald, based in Edinburgh, GB, is a notable inventor who has made significant contributions to the field of genetic research and biotechnology. With two patents to his name, he has innovated methods that could pave the way for advancements in agriculture and medicine, specifically in the realm of animal genetics.
Latest Patents
Archibald's latest patents showcase his expertise and inventive vision. The first patent, titled "Porcine polymorphisms and methods for detecting them," focuses on identifying pigs resistant or non-resistant to enterotoxigenic E. coli (ETEC). This invention provides methods, probes, and DNA molecules aimed at determining a pig's genetic response to ETEC, along with breeding techniques to enhance resistance against this pathogen.
His second patent, "Production of heterologous protein in milk of transgenic non-human mammals comprising a construct with an intron," details a method for producing proteinaceous products through transgenic animals. This involves integrating specific genetic constructs into mammals' genomes, allowing for the production of proteins such as serine proteases or blood factors in their milk. The innovation leverages the 5'-flanking sequence from mammalian milk protein genes to drive the expression of heterologous proteins.
Career Highlights
Throughout his career, Alan Archibald has been associated with prominent institutions that have helped shape his research and innovations. Notably, he has worked at the University of Copenhagen, where he honed his skills in genetic research. He has also contributed to PPL (Holdings) Limited, further expanding his expertise in biotechnology and transgenic studies.
Collaborations
Collaboration has been a key component in Archibald's journey as an inventor. Notably, he has partnered with Claus Böttcher Jörgensen and Susanna Cirera, both of whom have played significant roles in his research initiatives. Their combined efforts reflect the importance of teamwork in the innovative process, especially in complex fields such as genetics.
Conclusion
Alan Archibald’s contributions to the field of biotechnology highlight the significant impact of innovative thinking. His patents not only advance our understanding of genetic resistance in animals but also open doors for future developments in protein production. As he continues to push the boundaries of science, Archibald stands out as a visionary inventor dedicated to addressing key challenges in agriculture and medicine through his work.